Evidence map›Paper›PMID 36438959›Full record

ArticleFrontiers in neurology2022

Subclinical alterations of resting state functional brain network for adjunctive bright light therapy in nonseasonal major depressive disorder: A double blind randomized controlled trial.

Chun-Chao Huang, Hui-Chun Huang, Chen-Ju Lin, Chien-Chi Hsu, Chau-Shoun Lee, Yu-Hsin Hsu, Ting-Lin Chen, Wei-Hsin Liao, Yun-Hsiang Wu, Fan-Pei Gloria Yang and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03941301 (Light Therapy on Major Depression Disorder), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03941301 nacompletednot on this map

Light Therapy on Major Depression Disorder

TypeinterventionalSponsorMackay Memorial HospitalRan2019 to 2020Enrolled43ConditionsDepressive DisorderArmsLight therapy
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Chun-Chao HuangDepartment of Radiology, MacKay Memorial Hospital, Taipei, Taiwan.
Hui-Chun HuangMacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
Chen-Ju LinDepartment of Psychiatry, MacKay Memorial Hospital, Taipei, Taiwan.
Chien-Chi HsuDepartment of Medicine, MacKay Medical College, New Taipei, Taiwan.
Chau-Shoun LeeDepartment of Medicine, MacKay Medical College, New Taipei, Taiwan.
Yu-Hsin HsuDepartment of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, NY, United States.
Ting-Lin ChenDepartment of Radiology, MacKay Memorial Hospital, Taipei, Taiwan.
Wei-Hsin LiaoDepartment of Radiology, MacKay Memorial Hospital, Taipei, Taiwan.
Yun-Hsiang WuDepartment of Foreign Languages and Literature, National Tsing Hua University, Hsinchu, Taiwan.
Fan-Pei Gloria YangDepartment of Foreign Languages and Literature, National Tsing Hua University, Hsinchu, Taiwan.
Shen-Ing LiuDepartment of Medicine, MacKay Medical College, New Taipei, Taiwan.
Mackay Memorial Hospital · TWMackay Medical College · TWColumbia University · USNational Tsing Hua University · TWOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The treatment effect of bright light therapy (BLT) on major depressive disorder (MDD) has been proven, but the underlying mechanism remains unclear. Neuroimaging biomarkers regarding disease alterations in MDD and treatment response are rarely focused on BLT. This study aimed to identify the modulatory mechanism of BLT in MDD using resting-state functional magnetic resonance imaging (rfMRI). Materials and methods: This double-blind, randomized controlled clinical trial included a dim red light (dRL) control group and a BLT experimental group. All participants received light therapy for 30 min every morning for 4 weeks. The assessment of the Hamilton Depression Rating Scale-24 (HAMD-24) and brain MRI exam were performed at the baseline and the 4-week endpoint. The four networks in interest, including the default mode network (DMN), frontoparietal network (FPN), salience network (SN), and sensorimotor network (SMN), were analyzed. Between-group differences of the change in these four networks were evaluated. Results: There were 22 and 21 participants in the BLT and dRL groups, respectively. Age, sex, years of education, baseline severity, and improvement in depressive symptoms were not significantly different between the two groups. The baseline rfMRI data did not show any significant functional connectivity differences within the DMN, FPN, SN, and SMN between the two groups. Compared with the dRL group, the BTL group showed significantly increased functional connectivity after treatment within the DMN, FPN, SN, and SMN. Graph analysis of the BLT group demonstrated an enhancement of betweenness centrality and global efficiency. Conclusion: BLT can enhance intra-network functional connectivity in the DMN, FPN, SN, and SMN for MDD patients. Furthermore, BLT improves the information processing of the whole brain. Clinical trial registration: The ClinicalTrials.gov identifier was NCT03941301.

Indexed as

bright light therapyfunctional MRIfunctional networkgraph theorymajor depressive disorder

Identifiers

PMID36438959
PMCPMC9681819
OpenAlexW4308719508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.